Durvalumab vs Gabapentin
Durvalumab vs Gabapentin: Overview
This comparison examines the pharmacological differences between Durvalumab and Gabapentin.
Mechanism of Action
Durvalumab: Human IgG1 kappa anti-PD-L1 monoclonal antibody blocking PD-L1 binding to PD-1 and CD80.
Gabapentin: Binds alpha-2-delta subunit of voltage-gated calcium channels.
Pharmacokinetics
Half-life: Durvalumab β 17 days; Gabapentin β 5-7 hours.
Chemical Properties
Molecular Formula: Gabapentin β C9H17NO2.
Molecular Weight: Gabapentin β 171.2370 g/mol.
Type: Durvalumab β Antibody; Gabapentin β Small molecule.